Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874236 · ClinicalTrials.gov registry record · Phase 4
Validity and Reliability of Diagnostic Findings of SI Joint Blocking
A Phase 4 study, sponsored by SI-BONE.
- Terminated
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT01874236: Clinical Trial Phase 4 study, sponsored by SI-BONE.
NCT01874236 is a Phase 4 study that was terminated before completion, run by SI-BONE. The registered enrollment target is 28 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01874236, a Phase 4 study, was terminated before completion, sponsored by SI-BONE.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of the trial is to confirm the validity and reliability of diagnostic SI joint blocks.
Primary Outcome
Change in SI joint pain from prior to injection to 30 minutes, 60 minutes, 2 hours, 4 hours after injection. Changes compared over 3 injections, where type of block is blinded. Is response to bupivacaine different than response to sham block Is response to bupivacaine during second injection similar to that during first injection?
Interventions
- DRUG 0.75% bupivacaine
- DRUG .75% bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-04-22 |
| Est. Completion | 2014-09-30 |
| Phase | Phase 4 |
Why NCT01874236 stopped before completion
NCT01874236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which 0.75% bupivacaine is the first listed.
NCT01874236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01874236 about?
NCT01874236 is a clinical study titled "Validity and Reliability of Diagnostic Findings of SI Joint Blocking". The purpose of the trial is to confirm the validity and reliability of diagnostic SI joint blocks.
What is the current status of trial NCT01874236?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2013-04-22. Estimated completion is 2014-09-30.
What interventions are being tested in trial NCT01874236?
The interventions under investigation include: 0.75% bupivacaine (DRUG), .75% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01874236?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01874236's enrollment target sits among peer trials
28 1635th of 2000 higher than 350 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI